Related Experiment Video
Updated: May 14, 2026

Histological Analyses of Acute Alcoholic Liver Injury in Zebrafish
Published on: May 25, 2017
RNA interference against discoidin domain receptor 2 ameliorates alcoholic liver disease in rats
Zheng Luo1, Huimin Liu, Xiaomeng Sun
1Department of Geriatric Gastroenterology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Abstract:
Discoidin domain receptor 2 (DDR2) is involved in fibrotic disease. However, the exact pathogenic implications of the receptor in early alcoholic liver disease are still controversial. We constructed plasmid vectors encoding short-hairpin RNA against DDR2 to investigate its role in alcoholic liver disease in an immortalized rat hepatic stellate cell line, HSC-T6, and in rats by MTT, RT-PCR and western blot analyses; immunohistochemistry and electron microscopy. Alcohol-induced upregulation of DDR2 was associated with the expression of matrix metalloproteinase 2, the transforming growth factor β1 signaling pathway and tissue inhibitor of metalloproteinase 1; collagen deposition; and extracellular matrix remodeling. Inhibition of DDR2 decreased HSC-T6 cell proliferation and liver injury in rats with 10-week-induced alcoholic liver disease. DDR2 may have an important role in the pathogenesis of early-stage alcoholic liver disease. Silencing DDR2 may be effective in preventing early-stage alcoholic liver disease.
Insights
Discoidin domain receptor 2 (DDR2) plays a key role in early alcoholic liver disease. Inhibiting DDR2 reduced liver injury and cell proliferation, suggesting it as a potential therapeutic target.
Area of Science:
- Hepatology
- Molecular Biology
- Fibrosis Research
Background:
- Fibrotic diseases are often linked to discoidin domain receptor 2 (DDR2).
- The specific role of DDR2 in early alcoholic liver disease (ALD) remains unclear.
- Understanding DDR2's function is crucial for developing targeted therapies for ALD.
Purpose of the Study:
- To investigate the pathogenic role of DDR2 in early alcoholic liver disease.
- To assess the therapeutic potential of inhibiting DDR2 in ALD.
Main Methods:
- Construction of plasmid vectors for short-hairpin RNA (shRNA) against DDR2.
- Utilized immortalized rat hepatic stellate cell line (HSC-T6) and a rat model of ALD.
- Employed MTT assays, RT-PCR, western blot, immunohistochemistry, and electron microscopy.
Main Results:
- Alcohol exposure upregulated DDR2, correlating with matrix metalloproteinase 2, TGF-β1 signaling, TIMP-1, collagen deposition, and ECM remodeling.
- Inhibition of DDR2 significantly reduced HSC-T6 cell proliferation.
- Silencing DDR2 decreased liver injury in rats with 10-week-induced ALD.
Conclusions:
- DDR2 is implicated in the pathogenesis of early-stage alcoholic liver disease.
- Targeting DDR2 through silencing may offer a preventative strategy for early ALD.
Related Concept Videos
Chronic Pancreatitis II: Pathophysiology
Cirrhosis II: Pathophysiology
